SAN FRANCISCO, and CAMBRIDGE, Mass., March 16, 2018 /PRNewswire/ — Invitae Corporation (NYSE: NVTA) and KEW, Inc. today announced a collaboration to develop comprehensive genomic profiling solutions for sequencing tumor DNA on Invitae’s next generation sequencing (NGS) platform. By…
